GW Pharmaceuticals (NASDAQ:GWPH) stock increased 2.08% or $2.30 November 3, reaching $113.12 following news that its cannabidiol-based drug candidate Epidiolex has been formally submitted to the Food and Drug Administration for review. If approved, it will allow GW to market Epidiolex in the U.S. The stock has risen 31.90% since November 5, 2016, outperforming the […]

by

GW Pharmaceuticals (NASDAQ:GWPH) stock increased 2.08% or $2.30 November 3, reaching $113.12 following news that its cannabidiol-based drug candidate Epidiolex has been formally submitted to the Food and Drug Administration for review. If approved, it will allow GW to market Epidiolex in the U.S. The stock has risen 31.90% since November 5, 2016, outperforming the […]

by

Dr. Sue Sisley, a medical marijuana researcher, speaks at the Arizona Secretary of State’s Office Wednesday, April 14, 2010 at the Capitol in Phoenix. (AP Photo/Matt York) When the U.S. Food and Drug Administration (FDA) warned cannabidiol producers against making medical claims about cannabis products, it seemed par for the course for any federal agency. Cannabis […]

by

​Earlier this week, the U.S. Food and Drug Administration (FDA or the Agency) issued Warning Letters to four companies – Greenroads Health, Natural Alchemist, That’s Natural! Marketing and Consulting, and Stanley Brothers Social Enterprises LLC – citing unsubstantiated claims related to more than 25 different products sold online that allegedly contain cannabidiol (CBD), a component […]

by

The FDA has said it is increasingly concerned about unapproved cannabis and related products that claim to prevent, diagnose and even cure cancer. In a strongly-worded statement the FDA said it had sent warning letters to four companies warning that their actions are against US laws and put patients at risk by preventing them accessing […]

by

Morgan Stanley’s research team in January 2017 forecast that biotech-pharmaceutical companies – with a combined $75 billion in cash on hand – would strategize to boost revenue growth through mergers and acquisitions of smaller companies with high-potential product pipelines (http://nnw.fm/mN24x). Growth via strategic acquisition makes more sense to cost-conscious Big Pharma than does shelling out […]

by

Petitions will be out in the recall effort regarding Black Diamond Councilmember Pat Pepper beginning Friday, May 26. Petition gatherers upset with the way Pepper has conducted – or in many opinions – has not conducted the business of the City will hit the streets of the City over the next few weeks to gather […]

by

By Alicia Wallace, The Cannabist Staff A CBD-based pharmaceutical drug in development is one more step closer to potential FDA approval. Earlier this week, London-based GW Pharmaceuticals plc, which operates in the United States as Greenwich Biosciences, wrapped up its New Drug Application for Epidiolex, a formulation of the cannabis compound cannabidiol (CBD) for the […]

by

Earlier this week, the U.S. Food and Drug Administration (FDA or the Agency) issued Warning Letters to four companies – Greenroads Health, Natural Alchemist, That’s Natural! Marketing and Consulting, and Stanley Brothers Social Enterprises LLC – citing unsubstantiated claims related to more than 25 different products sold online that allegedly contain cannabidiol (CBD), a component […]

by

By Alicia Wallace, The Cannabist Staff A CBD-based pharmaceutical drug in development is one more step closer to potential FDA approval. Earlier this week, London-based GW Pharmaceuticals plc, which operates in the United States as Greenwich Biosciences, wrapped up its New Drug Application for Epidiolex, a formulation of the cannabis compound cannabidiol (CBD) for the […]

by